APHA
Tilray Q4 2018 Earnings – Eye Watering Stock Price Hard to Justify
Bottom Line This is likely a quarter Tilray's management wants to forget. Revenue of C$20.9 million missed even the low…
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…
Aphria Granted License Amendment, On Track to be a Market Leader by Summer
Bottom Line Aphria Inc. (TSX: APHA; NYSE: APHA) achieved a new milestone in the company's expansion plans today with a license amendment…
Aphria Inks Deal With Manna Molecular Science to Produce Cannabis Patches
The hunt for new cannabis-related products is on following nationwide legalization in Canada. While many companies are looking towards the…
All Time Highs (Episode 10) Aurora/Canopy Earnings and Aphria Special Committee
This week, Thomas George discusses Aurora (NYSE: ACB) and Canopy (NYSE: CGC) latest earnings as well as the conclusions from Aphria's…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (February 16th, 2019)
Canopy Growth Q2 2019 Earnings Review Bottom Line: Will Canopy Growth's earnings drive the industry to new highs, or will…
Aphria Special Committee Findings Remove Large Overhang on Shares
Bottom Line The special committee findings confirm that the Quintessential Capital Management short report was nothing more than an accusation…
Canopy Growth Q2 2019 Earnings Review – Big Growth With a Big Cost Structure to Match
Bottom Line: Investors will probably like this earnings release from Canopy Growth (TSE: WEED; NYSE: CGC). Net revenue of $83…
Althea Launches UK Subsidiary After Deal With Aphria
Australian cannabis producer Althea (ASX: AGH) has become one of the first companies to enter the UK medicinal marijuana market.…